98%
921
2 minutes
20
Objective: Main goal is to optimize the hyperparameters of ResNet-50 using the Walrus Optimization Algorithm (WaOA) to enhance classification performance for renal malignancy detection. The study aims to compare the WaOA-optimized ResNet-50 with conventional deep learning models, evaluate its effec-tiveness through various performance metrics, and integrate Occlusion Sensitivity Analysis to ensure model interpretability and transparency in AI-driven medical diagnosis.
Methods: A total of 12,446 abdominal CT images were collected from multiple hospitals in Dhaka, Bangladesh, comprising four diagnostic categories: cyst (3,709 images), normal (5,077), stone (1,377), and tumor (2,283). Several deep learning models AlexNet, GoogLeNet, Inception V3, and ResNet-50 were trained and evaluated. The Walrus Optimization Algorithm (WaOA) was implemented to fine-tune hy-perparameters, including weight and bias learning rate for ResNet-50. The models were assessed using various performance metrices. Additionally, Occlusion Sensitivity Analysis was applied to visualize and interpret the model's decision-making process by identifying critical regions in CT images that influence classification.
Result: The WaOA-optimized ResNet-50 achieved superior performance with 94.53% accuracy, outper-forming other models in precision (93.28%), recall (91.32%), F1-score (92.16%), and AUC-ROC (99.33%), indicating enhanced diagnostic efficiency. The model demonstrated a strong MCC (0.9038) and lower log loss (0.1597), ensuring better reliability and confidence in predictions. Despite a slightly higher inference time (0.1133 sec), accuracy and computational efficiency was minimal.
Conclusion: This article confirms the use of metaheuristic-based hyperparameter tuning for deep learning models in medical imaging. The WaOA-optimized ResNet-50 demonstrates significant improve-ments over conventional models, making it a promising tool for renal malignancy detection. The integra-tion of Occlusion Sensitivity Analysis ensures transparency and reliability in AI-assisted diagnosis. Future work can explore hybrid optimization techniques, multi-modal learning, and real-time clinical deployment to further enhance the model's applicability in healthcare.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.31557/APJCP.2025.26.8.2995 | DOI Listing |
Intern Med
September 2025
Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Japan.
We herein report two cases of immunotactoid glomerulopathy (ITG) associated with multiple myeloma treated with daratumumab-based regimens. The first patient was an 81-year-old woman with severe renal insufficiency and IgAκ multiple myeloma (MM) that progressed to end-stage renal disease despite administering daratumumab-based therapy. The second patient, a 69-year-old man with smoldering MM, showed a favorable response to daratumumab-based treatment, with a resolution of nephrotic proteinuria.
View Article and Find Full Text PDFTransl Oncol
September 2025
Pharmacy of Jiangxi cancer hospital&institute, Nanchang, Jiangxi, China. Electronic address:
Background: Renal cell carcinoma (RCC) is a common malignant tumor with metabolic reprogramming and immune evasion features. δ-Aminolevulinic acid dehydratase (ALAD), a key enzyme in heme biosynthesis, has been implicated in cancer progression and treatment outcomes, but its role in RCC remains unclear.
Methods: This study integrated multi-omics datasets from TCGA, CPTAC, and GEO to analyze ALAD's expression, prognostic value, and functional implications in RCC.
Eur J Case Rep Intern Med
August 2025
Nephrology Department, Unidade Local de Saúde de Braga, Braga, Portugal.
Introduction: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is widely used in oncology for its anti-angiogenic properties. However, VEGF inhibition may result in significant nephrotoxicity, including thrombotic microangiopathy (TMA). While systemic TMA is well-described, isolated renal-limited TMA remains under recognised.
View Article and Find Full Text PDFCase Rep Pathol
September 2025
Faculty of Medicine, KCMC University, Moshi, Tanzania.
Synovial sarcomas are rare malignant soft tissue tumors with significant metastatic potential. Although they can occur in various parts of the body, they are most commonly found on the extremities. These tumors typically develop in children and young adults, making occurrences in individuals over 50 years of age unusual.
View Article and Find Full Text PDFIndian J Nucl Med
August 2025
Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Metastatic renal osteosarcoma is a rare entity. We report a case of a 52-year-old male postright nephrectomy status presented to us with metastatic renal osteosarcoma. 18-fluorine- fluorodeoxyglucose (F-FDG) avid lesions were seen in the right renal bed with extension to adjacent hepatic parenchyma.
View Article and Find Full Text PDF